Rachel M. Slaton

Prevalence of Depression and Anxiety among Student Pharmacists

Katherine R. Smith, A. Smith, R. Dehart, 2020, International Journal of Medicine and Pharmacy.

Adverse events of smoking cessation treatments (nicotine replacement therapy and non-nicotine prescription medication) and electronic cigarettes in the Food and Drug Administration Adverse Event Reporting System, 2004−2016

Yumi Motooka, Ryogo Umetsu, S. Sasaoka, 2018, SAGE open medicine.

Evidence for Therapeutic Uses of Nebulized Lidocaine in the Treatment of Intractable Cough and Asthma

Rachel M. Slaton, R. H. Thomas, Joseph Wallace Mbathi, 2013, The Annals of pharmacotherapy.

Common issues in the medication use processes in nursing homes: a review of medication use quality improvement strategies

Peter J. Hughes, M. K. Freeman, Rachel M. Slaton, 2016 .

Varenicline in the Treatment of Alcohol Use Disorders

Rachel M. Slaton, Beth L. Erwin, 2014, The Annals of pharmacotherapy.

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease.

D. Cruthirds, Rachel M. Slaton, Danielle L. Cruthirds, 2012, P & T : a peer-reviewed journal for formulary management.

Student-led development, delivery, and assessment of an integrated learning activity focusing on acute myocardial infarction

M. Kendrach, M. Monk-Tutor, Rachel M. Slaton, 2012 .

Evidence for Therapeutic Uses of Nebulized Lidocaine in the Treatment of Intractable Cough and Asthma

Rachel M. Slaton, R. H. Thomas, Joseph Wallace Mbathi, 2013, The Annals of pharmacotherapy.

A Review of Paroxetine for the Treatment of Vasomotor Symptoms

Rachel M. Slaton, Megan N Champion, Kayla B Palmore, 2015, Journal of pharmacy practice.